Esomeprazole is a proton pump inhibitor that reduces the amount of acid in the stomach. The esomeprazole capsules are also approved to reduce the risk of gastric ulcers associated with use of non-steroidal anti-inflammatory drugs.
Ivax Pharmaceuticals, a subsidiary of Teva Pharmaceuticals USA, developed the capsules.
More articles on GI/endoscopy:
14 statistics on gastroenterologist burnout
GI physician leader to know: Dr. Peter Banks of Brigham and Women’s Hospital
Actavis to acquire Auden Mckenzie for approximately $460M
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
